SINGAPORE -- The International Association for the Study of Lung Cancer 2023 World Congress of Lung Cancer (IASLC 2023 WCLC), held Sept. 9-12 in Singapore, featured many milestone studies in treating lung cancer.AstraZeneca showed a particularly remarkable performance.Its Tagrisso (osimertinib), a t
CHA Vaccine Institute said on Thursday it has obtained a Canadian patent for its Lipo-pam immune enhancer, recognizing it as an adjuvant for vaccines that include a liposome with the lipopeptide as the active ingredient.The patent covers both the vaccine and the associated method for manufacturing v
Gilead Sciences said it has appointed Choi Jae-yeon, the former Managing Director of MSD Taiwan, as the new general manager of its Korea offshoot.Choi will oversee Gilead's operations in Korea, with a focus on developing business in areas such as HIV, viral hepatitis, Covid-19, antifungal treatments
Aiming to provide a holistic and personalized healthcare platform that is easy and enjoyable to encourage daily healthcare management, Lotte Healthcare revealed its business plan, platform features, and security policies of Cazzle, a personalized healthcare platform.Lotte Healthcare held a press con
Korean pharmaceutical companies have received a heap of administrative penalties from the Ministry of Food and Drug Safety (MFDS), causing a stir.On Monday, GC Wellbeing, a subsidiary of the GC Group, received a one-month suspension of manufacturing four specialized drugs from the MFDS. As a result,
In the recent pilot program for telemedicine, over 57.2 percent of the prescribed medications were non-reimbursed drugs, a survey showed.The survey, conducted by the Korean Pharmaceutical Association (KPA) during the telemedicine pilot program run between June and August, was on 1,142 member pharmac
Poor treatment landscape for TNBCDespite Korea's excellent breast cancer treatment record, as evidenced by a 93.8 percent five-year survival rate for breast cancer from 2016 to 2020 according to national cancer statistics, there remains a formidable challenge in triple-negative breast cancer (TNBC).
Korea Biomedical Review is publishing a series of articles to analyze the top 10 Korean pharmaceutical and biopharma companies with the largest market capitalizations listed on the main bourse, Kospi, and the tech-heavy Kosdaq. The series aims to reflect key industrial issues and the flow of the cap
Hanmi Science said on Wednesday that it plans to pursue obesity management as a strong growth engine to build a unique portfolio called, the "Hanmi Obesity Pipeline (H.O.P)."Recently, Danish biotech company Novo Nordisk has gained significant media attention for its weight loss drug, Wegovy (ingredi
AriBio, a biotech firm specializing in medicines for neurodegenerative and infectious disease, said Wednesday it has signed a memorandum of understanding for strategic collaboration with Shanghai Pharmaceuticals, the second-largest pharmaceutical distributor in China.The main contents of the MOU inc
If people do walking exercises to the point of sweating and shortness of breath after middle age, they could slow or prevent Alzheimer's disease-related cognitive decline, a new study has found.A group of researchers at Hallym University Dongtan Sacred Heart Hospital said Wednesday that they made th
A research team at the Korean Advanced Institute of Science and Technology (KAIST) and Asan Medical Center (AMC) said that they have developed the "world's first" organic light-emitting diode (OLED)-based catheter for phototherapy within internal organs.Traditionally, the application of light therap
VUNO, a medical artificial intelligence (AI) company, said on Wednesday that a multi-center clinical research paper demonstrated the clinical efficacy of its AI medical solution, VUNO Med-DeepCARS. This marks the first prospective study to demonstrate the superior predictive performance of VUNO Med-
Coreline Soft, a developer of artificial intelligence (AI) medical imaging software, has signaled a transition to profitability within two years of its expected listing.The company is set to merge with Shinhan No. 7 Pack and the Special Purpose Acquisition Company (SPAC) and will be listed on the KO
The Ministry of Food and Drug Safety (MFDS) has rolled up its sleeves to support the development of homegrown anticancer drugs by, for instance, providing customized counseling and clinical trial design support.Kim Young-rim, head of the Drug Review Division at the National Institute of Food and Dru
SINGAPORE -- “The FLAURA2 study is the first to demonstrate progression-free survival (PFS) improvement with a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) plus chemotherapy. I’d say the result was a home run.”Dr. Pasi A. Jänne of Dana-Farber Cancer Instit
After the devastating impacts of the Covid-19 pandemic, many countries are striving to achieve vaccine sovereignty and Korea is one of them. However, the WHO Pandemic Treaty which is carded to be further discussed next week in a UN High Level Meeting, has drawn the attention of Korean vaccine manufa
Philips Korea said it has launched MR 7700, one of its newest magnetic resonance imaging devices, on Wednesday.The company stressed that the product stands out in the crowded MR diagnostic market with its newly designed XP gradients, offering significant improvements over its predecessors.According
Samsung Biologics said on Wednesday that Samsung Life Science Fund made an equity investment in AIMEDBIO, a domestic company specializing in therapeutic solutions for neuro-oncological and neuro-degenerative diseases.This marks the fund’s fourth investment after previous investments in foreign compa
Severance Hospital has marked another groundbreaking achievement by successfully operating on Mikhael Josepine Haresananda, a 7-year-old Indonesian boy born with a rare condition where his heart was outside his body.Haresananda was born with ectopia cordis, a mysterious ailment affecting 1 in 200,00